Dmytruk Mark E. (CIK 1873507) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-22). Recent activity: Buy DNA (454 shares), Buy DNA (453 shares), Buy DNA (572 shares), Sell DNA (706 shares), Buy DNA (454 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-22 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 454 | $0 |
| 2025-05-22 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 453 | $0 |
| 2025-05-22 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 572 | $0 |
| 2025-05-22 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Sell | 706 | $5,359 |
| 2025-04-23 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 454 | $0 |
| 2025-04-23 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 453 | $0 |
| 2025-04-23 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 572 | $0 |
| 2025-04-23 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 1,061 | $0 |
| 2025-04-23 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Buy | 8 | $0 |
| 2025-04-23 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | Sell | 1,244 | $9,056 |
来源：SEC Form 4 申报文件 · 截至 2025-05-22